About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

HISAMITSU PHARMACEUTICAL CO.,INC.(4530) Summary

4530
TSE Prime
HISAMITSU PHARMACEUTICAL CO.,INC.
4,470
JPY
+47
(+1.06%)
Apr 16, 3:30 pm JST
31.39
USD
Apr 16, 2:30 am EDT
Result
PTS
outside of trading hours
4,468.7
Apr 16, 3:24 pm JST
Summary Chart Historical News Financial Result
PER
14.8
PBR
1.18
Yield
2.68%
Margin Trading Ratio
3.06
Stock Price
Apr 16, 2025
Opening Apr 16, 9:00 am
4,438 JPY 31.00 USD
Previous Close Apr 15
4,423 JPY 30.93 USD
High Apr 16, 10:20 am
4,480 JPY 31.43 USD
Low Apr 16, 9:23 am
4,400 JPY 30.76 USD
Volume
233,900
Trading Value
1.04B JPY 7.32M USD
VWAP
4454.42 JPY 31.3 USD
Minimum Trading Value
447,000 JPY 3,139 USD
Market Cap
0.38T JPY 2.68B USD
Number of Trades
1,073
Liquidity & Number of Trades
As of Apr 16, 2025
Liquidity
Slightly High
1-Year Average
662
1-Year High Jan 10, 2025
9,010
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 11, 2025 23,100 45,200 1.96
Apr 4, 2025 9,600 44,900 4.68
Mar 28, 2025 10,000 50,500 5.05
Mar 21, 2025 8,900 59,900 6.73
Mar 14, 2025 7,200 56,700 7.88
Company Profile
HISAMITSU PHARMACEUTICAL CO.,INC. is the market leader in anti-inflammatory analgesic patches, with its "Salonpas" brand being widely recognized. The company is strengthening its presence overseas, particularly in the United States and China.
Sector
Pharmaceuticals
HISAMITSU PHARMACEUTICAL CO.,INC. is the leading manufacturer of topical anti-inflammatory and analgesic patches. While the company operates broadly both domestically and internationally, its business segment focuses solely on pharmaceuticals. In Japan, in addition to its own manufacturing and sales operations, the company has numerous consolidated subsidiaries and actively collaborates with affiliated companies. Overseas, HISAMITSU operates in many countries and regions including the United States, Brazil, Europe, Vietnam, China, Hong Kong, Malaysia, and Indonesia. Subsidiaries in each country handle manufacturing, sales, and development activities, creating a global network. Although the company is involved in other businesses such as cable television broadcasting and internet connection services, these have minimal impact on the company's overall performance.